Show summary Hide summary
The New York Mets face a pivotal offseason choice: do they reinvest heavily in pitching, or take a more cautious path? Team owner Steve Cohen appears willing to spend. General manager David Stearns has shown restraint in past deals. Their next moves will shape the roster and the team’s 2025 outlook.
How the Mets are weighing a big pitching push
New York’s decision hinges on balancing short-term needs with long-term payroll flexibility. A marquee starter would change the rotation immediately. But that commitment could limit moves elsewhere.
$110M reliever: will Mets still pursue after Edwin Diaz’s issues?
Little Rascals star Brandon Bug Hall’s shocking fall after leaving Hollywood
- Payroll vs. competitiveness: Cohen has deep pockets, but Stearns must consider contract length and fit.
- Rotation health: The Mets need reliable innings after injury uncertainty in recent years.
- Market dynamics: Competing teams will drive up prices for top arms.
Tarik Skubal: the high-profile option under consideration
Tarik Skubal has emerged as one of the most talked-about free agents. Reports linked to industry analysis project a sizable contract.
The Athletic’s estimate: five years and $110 million — a deal that would make Skubal a centerpiece for any rotation. That price reflects both upside and risk.
- Pros: strikeout ability, swing-and-miss stuff, potential frontline starter.
- Cons: health history and innings workload could give teams pause.
- Fit: a pitcher of Skubal’s profile would address the Mets’ need for an ace-caliber arm.
Relief pitching: caution after the Edwin Diaz investment
New York’s bullpen spending has already been notable. The club handed out a big contract to Edwin Diaz, and results have not always matched expectations.
That experience raises a question: will the Mets again pay market-leading dollars for a reliever? The answer affects their strategy for late-inning stability.
- Options include signing another high-priced arm or hunting for cost-effective, high-leverage pieces.
- Internal alternatives and reclamation projects could provide depth without the same price tag.
- Front office risk tolerance will shape which path they choose.
Front office chemistry: Cohen and Stearns’ shared vision
On many roster priorities, owner and GM appear aligned. Yet differences remain over how far to push the payroll for starters.
Decision-making dynamics
Stearns evaluates long-term roster construction. Cohen can authorize bold signings. Their collaboration will determine if New York chases an elite arm or spreads resources.
Likely scenarios for the Mets this winter
- Sign a top-tier starter to a multi-year deal and adjust payroll accordingly.
- Prioritize mid-range starters and invest savings in bullpen upgrades.
- Lean on internal depth and pursue low-cost relievers or trade opportunities.
- Make a mixed approach: one big addition plus targeted bullpen pieces.
Other MLB storylines to watch
- Could the Blue Jays quietly land a postseason star valued at $108 million?
- Tigers’ odds of re-signing Tarik Skubal seem to be slipping after massive contract chatter.
- A trade idea would give the Blue Jays an All-Star boost and shake up the AL East race.
- Aaron Judge has faced criticism tied to reports about Jazz Chisholm Jr.’s attitude.
- The Yankees reportedly have new options to replace Ryan McMahon’s production.
